Quick Answer: Syn-Ake is the trade name often used for Dipeptide Diaminobutyroyl Benzylamide Diacetate (CAS 823202-99-9). In leave-on serums and eye creams, it can support expression-line appearance concepts. Your pack and website copy should stay cosmetic: talk about how skin looks with topical use. Do not call it a Botox replacement, a neurotoxin, or a medical treatment. Lock the INCI and CAS on the formula file before marketing writes the hero line.
What This Article Is (and Is Not)
This guide is for brand managers, copywriters, and formulation leads who already plan to use Syn-Ake and now need claim-safe English wording.
It is not:
- A deep mechanism review
- A mixing or stability SOP
- Legal advice for every market
If you need those topics, start here instead:
- What is Dipeptide Diaminobutyroyl Benzylamide Diacetate? Syn-Ake vs Botox overview
- The science behind Dipeptide Diaminobutyroyl Benzylamide Diacetate
- Formulating with Syn-Ake: use level, pH, cool-down, and Argireline pairing
Step 1: Get the Name Right Before You Write Claims
Marketing likes short nicknames. Lab files and packaging need the exact identity.
| Use on pack / COA / formula file | Use carefully in consumer storytelling |
| INCI: Dipeptide Diaminobutyroyl Benzylamide Diacetate | “Inspired by temple-viper peptide research” (story only) |
| CAS: 823202-99-9 | “Snake venom peptide” as a nickname – never as the only identity |
| Trade reference: Syn-Ake (where permitted) | Dramatic “paralyzing toxin” language – avoid |
Confirm supply identity on the Dipeptide Diaminobutyroyl Benzylamide Diacetate (CAS 823202-99-9) product page before print files are locked.
Step 2: What You Can Say in Cosmetic Language
Keep claims tied to appearance, topical use, and expression-line care concepts. Safer directions usually include:
- Helps improve the appearance of expression lines with continued use
- Designed for leave-on serums targeting the look of crow’s feet or forehead creases
- A topical peptide option for shoppers who prefer a non-injectable daily routine
- Works well next to hydration actives for feel now + look over time
Always check final wording against your target market’s advertising rules and your own substantiation file. This article is practical drafting help – not a legal opinion.
Step 3: Phrases That Create Overclaim Risk
These lines create the highest risk for Syn-Ake products:
| Risky / avoid | Why it is a problem | Safer rewrite direction |
| “Botox in a bottle” / “replaces Botox” | Implies medical equivalence | “Topical option for daily expression-line care” |
| “Paralyzes muscles” / “neurotoxin” | Sounds like a poison or drug story | “Helps soften the look of expression lines” |
| “Clinically proven to erase wrinkles in X days” (without your own file) | Overstates results; may misuse third-party data | Cite only studies you are allowed to use; keep appearance language |
| “Works like injections” | Compares a cream to a medical procedure | “For shoppers who prefer a leave-on approach” |
| Guaranteed dramatic results for every user | Cosmetic results vary | “Results may vary; designed for daily use” |
For a clear efficacy boundary discussion, see: Can Syn-Ake smooth wrinkles like Botox?.
Step 4: Serum vs Eye Cream – Same INCI, Different Claim Weight
Same ingredient, different product job. Adjust tone and intensity:
| Format | Typical claim focus | Drafting tip |
| Face serum | Look of forehead lines, “elevens,” overall softer expression-line appearance | Lead with daily topical routine; avoid injection comparisons |
| Eye cream / eye serum | Look of crow’s feet; delicate eye-area care | Use softer language; emphasize gentle leave-on use |
| Multi-active cream | Syn-Ake as one pillar next to hydration or other care stories | Do not credit every benefit to Syn-Ake alone |
For process and use-level context, see Formulating with Syn-Ake – use level, pH, and cool-down.
Ready-to-Adapt Claim Lines (English Drafts)
Use these as starting points. Localize and run legal review before print.
Stronger (still cosmetic-leaning)
- “Helps reduce the appearance of expression lines with twice-daily use.”
- “A topical peptide serum featuring Dipeptide Diaminobutyroyl Benzylamide Diacetate (Syn-Ake).”
- “Targets the look of crow’s feet in a leave-on eye cream.”
Softer / supporting
- “Formulated with a Syn-Ake-class peptide for expression-line care concepts.”
- “Supports a smoother-looking finish as part of your daily routine.”
- “Pairs hydration with an expression-line peptide approach.”
Avoid even if traffic-friendly
- “Instant Botox effect.”
- “Freeze muscles overnight.”
- “Injection-level results without a needle.”
How to Tell the “Snake Venom” Story Without Crossing the Line
The temple-viper origin story sells – and also scares. Keep the story educational:
- Do say the ingredient is a synthetic peptide inspired by research on waglerin-related sequences.
- Do separate the marketing nickname from the INCI on your ingredient glossary page.
- Do not imply the cream contains venom or acts as a toxin.
- Do not use medical paralysis language to chase clicks.
More scientific background without claim overreach: The Science Behind Dipeptide Diaminobutyroyl Benzylamide Diacetate.
Claim File Checklist Before You Print
| File item | Pass look |
| INCI + CAS on master formula | Dipeptide Diaminobutyroyl Benzylamide Diacetate / 823202-99-9 |
| Finished use level documented | Matches the grade you actually buy (powder vs solution basis) |
| Substantiation folder | Only studies and claims your team is authorized to reference |
| Pack vs website consistency | Same intensity of language in both places |
| Market legal review | Signed off for EU / US / CN / other launch markets as needed |
| Translation check | No accidental “Botox” escalation in local language |
Need documented material while marketing and R&D align the brief? Contact Monuo Chem for COA, MSDS, and quotation support for Dipeptide Diaminobutyroyl Benzylamide Diacetate (CAS 823202-99-9), or email info@monuochem.com.
One-Page Handoff Between Marketing and the Lab
Give both teams the same short brief:
- Ingredient identity: CAS 823202-99-9 / INCI Dipeptide Diaminobutyroyl Benzylamide Diacetate
- Product job: serum or eye cream (pick one primary job)
- Allowed claim lane: appearance of expression lines / topical daily use
- Forbidden lane: Botox replacement / paralysis / medical treatment
- Process constraints for the chemist: cool-down and mild pH – see the formulating guide
FAQ
Can we say Syn-Ake is like Botox on the product page?
Not as a replacement claim. Topical Syn-Ake and injectable toxin procedures sit in different categories. Use appearance-based cosmetic language instead. Background: Syn-Ake vs Botox overview.
Is “snake venom peptide” allowed in marketing?
As a story nickname, it is common. It must not replace INCI/CAS identity, and it should not imply real venom or toxic action. Pair any storyline with clear synthetic-peptide wording.
What is a safer hero line for an eye cream?
Example direction: “Leave-on eye cream with Dipeptide Diaminobutyroyl Benzylamide Diacetate to help improve the appearance of crow’s feet.” Soften further if your market is strict.
Do we need different claims for serum vs cream?
Usually yes in emphasis. Serums can lean into expression-line appearance; eye products should stay gentler and area-specific. Do not copy-paste the strongest serum line onto an eye SKU without review.
Where can we source CAS 823202-99-9 for a claim-backed launch project?
Monuo Chemical supplies research- and cosmetic-grade Dipeptide Diaminobutyroyl Benzylamide Diacetate (Syn-Ake, CAS 823202-99-9) with COA, MSDS, and formulation support. See the product page for Dipeptide Diaminobutyroyl Benzylamide Diacetate (CAS 823202-99-9) or contact Monuo Chem.
Conclusion
Strong Syn-Ake products win twice: once in the formula, and once in the sentence on the pack. Keep CAS 823202-99-9 identity tight, keep claims in the appearance / topical lane, and leave injection comparisons out of the hero copy.
Monuo Chemical supplies research- and cosmetic-grade Dipeptide Diaminobutyroyl Benzylamide Diacetate with COA, MSDS, and formulation support.
Related Reading
- What is Dipeptide Diaminobutyroyl Benzylamide Diacetate? Can it really smooth out wrinkles just like Botox?
- The Science Behind Dipeptide Diaminobutyroyl Benzylamide Diacetate
- Formulating with Syn-Ake (CAS 823202-99-9): Use Level, pH, Cool-Down & Pairing with Argireline
- Dipeptide Diaminobutyroyl Benzylamide Diacetate (CAS 823202-99-9) product page
- Contact / Request a Quote
Disclaimer
Information is for cosmetic product communication and technical reference only. It is not legal advice. Finished-product claims, labeling, and regulatory filings remain the customer’s responsibility. Verify each lot against the supplied COA and SDS. Do not use medical or injectable claim language for topical peptide marketing.